SLAM
CLB icon

Swiss Life Asset Management’s Core Laboratories CLB Stock Holding History

Swiss Life Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,623
Closed -$195K – 1660
2026
Q1 		$195K Sell
11,623
-376
-3% -$6.73K ﹤0.01% 1395
2025
Q4 		$192K Buy
+11,999
New +$179K ﹤0.01% 1296

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
ECM
Evergreen Capital Management Bellevue, Washington $5.7B AUM 32.06% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swiss Life Asset Management's CLB Position: Q2 2026 in Review

Swiss Life Asset Management sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 11,623 shares — an estimated $195K sold.

Swiss Life Asset Management first reported a position in CLB in Q4 2025 and held it in 2 quarters. The position peaked at $195K in Q1 2026. 118 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Swiss Life Asset Management reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Swiss Life Asset Management sold 11,623 Core Laboratories shares in Q2 2026, an estimated $195K.
  • Swiss Life Asset Management first reported a position in Core Laboratories in Q4 2025 and held it in 2 quarters.
  • Swiss Life Asset Management's Core Laboratories position peaked at $195K in Q1 2026.
  • 118 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.